Form 8-K - Current report:
SEC Accession No. 0001125345-24-000149
Filing Date
2024-08-06
Accepted
2024-08-06 16:02:44
Documents
15
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20240806.htm   iXBRL 8-K 26926
2 EX-99.1 exhibit99-1earningspressre.htm EX-99.1 95176
6 macrogenics20logo_jpgormata.jpg GRAPHIC 139164
  Complete submission text file 0001125345-24-000149.txt   449333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20240806.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20240806_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20240806_pre.xml EX-101.PRE 12508
17 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20240806_htm.xml XML 2717
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 241179022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)